My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 214

    1.

    Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.

    Colhoun HM, Taskinen MR, Otvos JD, Van Den Berg P, O'Connor J, Van Tol A.

    Diabetes. 2002 Nov;51(11):3300-5.PMID: 12401722 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.

    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.

    Atherosclerosis. 2002 Aug;163(2):287-96.PMID: 12052475 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.

    Colhoun HM, Scheek LM, Rubens MB, Van Gent T, Underwood SR, Fuller JH, Van Tol A.

    Diabetes. 2001 Mar;50(3):652-9.PMID: 11246887 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.

    Riemens S, van Tol A, Sluiter W, Dullaart R.

    Atherosclerosis. 1998 Sep;140(1):71-9.PMID: 9733217 [PubMed - indexed for MEDLINE]Related articles

    5.

    Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.

    Jiang X, Francone OL, Bruce C, Milne R, Mar J, Walsh A, Breslow JL, Tall AR.

    J Clin Invest. 1996 Nov 15;98(10):2373-80.PMID: 8941656 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers.

    Liinamaa MJ, Hannuksela ML, Kesäniemi YA, Savolainen MJ.

    Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2940-7.PMID: 9409280 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

    Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.

    Diabetes. 2002 Jun;51(6):1949-56.PMID: 12031985 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease.

    Cheung MC, Wolfbauer G, Brown BG, Albers JJ.

    Atherosclerosis. 1999 Jan;142(1):201-5.PMID: 9920522 [PubMed - indexed for MEDLINE]Related articles

    9.

    Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.

    Dullaart RP, De Vries R, Scheek L, Borggreve SE, Van Gent T, Dallinga-Thie GM, Ito M, Nagano M, Sluiter WJ, Hattori H, Van Tol A.

    Scand J Clin Lab Invest. 2004;64(3):205-15.PMID: 15222630 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity.

    Cheung MC, Knopp RH, Retzlaff B, Kennedy H, Wolfbauer G, Albers JJ.

    Biochim Biophys Acta. 2002 May 21;1587(1):53-9.PMID: 12009424 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum phospholipid transfer protein activity and genetic variation of the PLTP gene.

    Tahvanainen E, Jauhiainen M, Funke H, Vartiainen E, Sundvall J, Ehnholm C.

    Atherosclerosis. 1999 Sep;146(1):107-15.PMID: 10487493 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.

    Riemens SC, van Tol A, Sluiter WJ, Dullaart RP.

    Diabetes. 1999 Aug;48(8):1631-7.PMID: 10426383 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.

    Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Artur Y, Paille F, Gambert P, Lallemant C.

    J Biol Chem. 1996 Aug 9;271(32):19058-65.PMID: 8702577 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.

    Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR.

    J Clin Invest. 1999 Mar;103(6):907-14.PMID: 10079112 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.

    Tan KC, Shiu SW, Wong Y, Wong WK, Tam S.

    Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):307-12.PMID: 16389649 [PubMed - indexed for MEDLINE]Related articles

    16.

    Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

    Cheung MC, Wolfbauer G, Deguchi H, Fernández JA, Griffin JH, Albers JJ.

    Biochim Biophys Acta. 2009 Mar;1791(3):206-11. Epub 2008 Dec 30.PMID: 19162221 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity.

    Schneider M, Vergès B, Klein A, Miller ER, Deckert V, Desrumaux C, Masson D, Gambert P, Brun JM, Fruchart-Najib J, Blache D, Witztum JL, Lagrost L.

    Diabetes. 2004 Oct;53(10):2633-9.PMID: 15448094 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.

    Cheung MC, Wolfbauer G, Albers JJ.

    Biochim Biophys Acta. 1996 Sep 27;1303(2):103-10.PMID: 8856039 [PubMed - indexed for MEDLINE]Related articles

    19.

    Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids.

    Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EH, Desrumaux C, Athias A, Hornstra G, Gambert P.

    Atherosclerosis. 1999 Feb;142(2):395-402.PMID: 10030391 [PubMed - indexed for MEDLINE]Related articles

    20.

    Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.

    Riemens SC, van Tol A, Sluiter WJ, Dullaart RP.

    Diabetologia. 1998 Aug;41(8):929-34.PMID: 9726595 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity